Supernus (SUPN) Cash & Equivalents (2021 - 2026)
Supernus Pharmaceuticals (SUPN) posted Cash & Equivalents of $175.88 million for Q3 2026, up 16.2% from $151.37 million a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
Supernus (SUPN) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals' Cash & Equivalents came in at $128.45 million, up 85.3% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -15.0% (FY2020 to FY2025).
- In prior years, Supernus Pharmaceuticals' Cash & Equivalents was $69.33 million in FY2024 (-7.6%), $75.05 million in FY2023 (-19.4%), $93.12 million in FY2022 (-54.2%) and $203.43 million in FY2021 (-29.5%).
- Quarterly Cash & Equivalents has run from a low of $24.71 million in Q2 2023 to a high of $203.43 million in Q4 2021 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last seven quarters, with growth averaging 102.0% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2025, with growth of 377.9%; the weakest was Q2 2023, with a decline of 85.8%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $179.95 million (Q2 2026), $184.87 million (Q1 2026) and $128.45 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Supernus | 3.39 Bn | 2.50 Bn | 305.00 Mn | 305.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 305.00 Mn |
| Jun 30, 2026 | 222.00 Mn |
| Mar 31, 2026 | 175.00 Mn |
| Dec 31, 2025 | 195.00 Mn |
| Sep 30, 2025 | 445.00 Mn |
| Jun 30, 2025 | 510.00 Mn |
| Mar 31, 2025 | 372.00 Mn |
| Dec 31, 2024 | 319.00 Mn |
| Sep 30, 2024 | 288.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | 316.00 Mn |
| Sep 30, 2023 | 610.00 Mn |
| Jun 30, 2023 | 592.00 Mn |
| Dec 31, 2022 | 774.00 Mn |
| Dec 31, 2021 | 1.10 Bn |
API Access
Supernus Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();